Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ototoxicity of loop diuretics

L P Rybak1

  • 1Department of Surgery, Southern Illinois University School of Medicine, Springfield.

Otolaryngologic Clinics of North America
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Loop diuretics can cause hearing loss by affecting the inner ear's stria vascularis. Research explores protective agents to prevent this ototoxicity while maintaining therapeutic benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.

Cell death & disease·2011
Same author

Ototoxicity.

Kidney international·2007
Same author

Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin.

Neuroscience·2006
Same author

Time response of carboplatin-induced hearing loss in rat.

Hearing research·2004
Same author

Carboplatin-induced oxidative stress in rat cochlea.

Hearing research·2001
Same author

Pharmacological antagonism of the slow-activating delayed rectifying potassium channel (I(Ks)) has no effect on cochlear structure and function in vivo.

Pharmacology & toxicology·2001
Same journal

Obesity and Obstructive Sleep Apnea: Impact on Medical and Surgical Management.

Otolaryngologic clinics of North America·2026
Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026
Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026
Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026
See all related articles

Area of Science:

  • Nephrology
  • Ototoxicology
  • Pharmacology

Background:

  • Loop diuretics are essential medications for managing fluid and electrolyte balance.
  • Clinical observations have raised concerns regarding the ototoxicity of loop diuretics.
  • Understanding the mechanisms of diuretic-induced hearing loss is crucial for patient safety.

Purpose of the Study:

  • To review clinical reports and experimental data on the ototoxicity of loop diuretics.
  • To elucidate the cellular and physiological effects of loop diuretics on the inner ear.
  • To explore potential strategies for mitigating hearing loss associated with loop diuretic use.

Main Methods:

  • Review of clinical case reports on hearing loss in patients using loop diuretics.
  • Analysis of experimental studies in animal models investigating the effects of loop diuretics on cochlear function.

Related Experiment Videos

  • Examination of histological and electrophysiological changes in the stria vascularis and endocochlear potential.

    • Main Results:

    • Loop diuretics can induce temporary or permanent hearing loss in patients.
    • Animal studies demonstrate that these drugs cause edema in the stria vascularis, impairing its function.
    • This dysfunction leads to a decrease in the endocochlear potential and secondary effects on hearing.

    Conclusions:

    • Loop diuretics pose a risk of ototoxicity, impacting hearing function through effects on the stria vascularis.
    • Further research into protective agents may allow for the preservation of hearing while utilizing the therapeutic benefits of these drugs.